Drug Prices
Amy Bricker
President
Express Scripts PBM
1 Express Way
Saint Louis, MO 63121
Dear Ms. Bricker:
Retail prices for 260 widely used brand-name prescription drugs last year increased by an average 2.9%, more than twice the general rate of inflation, according to a report released by AARP’s Public Policy Institute.
The Campaign for Sustainable Rx Pricing (CSRxP), of which the AHA is a founding member, launched new television and digital advertising encouraging policymakers to hold brand name drug companies accountable.
House Energy and Commerce Committee Chairman Frank Pallone Jr., D-NJ, re-introduced the Elijah E. Cummings Lower Drug Costs Now Act (H.R. 3) with other Democratic committee leaders.
The Campaign for Sustainable Rx Pricing launched a grassroots and digital advertising campaign urging policymakers to lower prescription drug prices.
The availability of swift, accurate and reliable diagnostic testing during the public health emergency has been extremely important.
The AHA and American Society of Health-System Pharmacists urged the Food and Drug Administration to take appropriate enforcement action to protect patients from a payer-mandated drug distribution model known as “white bagging.”
The AHA asks that commissioners consider the following issues as they recommend changes that would have a significant impact on hospitals, health systems and the Medicare patients we serve.
AHA letter to Senators, John Thune, Rob Portman, Shelley Moore Capito, Tammy Baldwin, Debbie Stabenow and Ben Cardin expressing support for legislation, S. 773.
Regulators should prohibit health insurers from preventing hospitals and physicians in their networks from directly acquiring and storing drugs used in patient care. A number of large health insurers are requiring these providers to accept drugs purchased or handled by their own or affiliated…